Clinical Trial Update: Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating liothyronine in children with single-ventricle congenital heart defects undergoing the Fontan procedure; the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Single-ventricle Congenital Heart Disease
• Tricuspid Atresia

Drugs mentioned

• Liothyronine (liothyronine)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Tricuspid Atresia, Heart Defects, Congenital | Phase 1 | Status: COMPLETED